A Study to Evaluate the Efficacy and Safety of AD-224

Clinical trial NCT06291207 · COMPLETED

Trial details

NCT number: NCT06291207
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension,Essential

Start date: 2024-04-15
Primary completion: 2025-04-07
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.